PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Translational Health Science and Technology Institute, Faridabad, India.\', \'Council of Scientific and Industrial Research-Institute of Genomics and Integrative Biology, New Delhi, India.\', \'ESIC Medical College and Hospital, Faridabad, India.\', \'Regional Centre for Biotechnology, Faridabad, India.\', \'National Institute of Immunology, Delhi, India.\', \'Translational Health Science and Technology Institute, Faridabad, India; International AIDS Vaccine Initiative, New Delhi, India.\', \'Translational Health Science and Technology Institute, Faridabad, India. Electronic address: pgarg@thsti.res.in.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1473-3099(21)00680-010.1016/S1473-3099(21)00680-0
?:hasPublicationType
?:journal
  • The Lancet. Infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34838183
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34838183>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34838183>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all